Clinical Trial Update: Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating interferon gamma-1b plus chemotherapy for ovarian cancer and peritoneal cancer was terminated; the update discusses safety and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Interferon gamma-1b (Actimmune) (Interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Ovarian Carcinoma, Peritoneal Carcinoma | Phase 3 | Status: TERMINATED